Efficient Expression of an Alzheimer’s Disease Vaccine Candidate in the Microalga Schizochytrium sp. Using the Algevir System
- 28 March 2018
- journal article
- research article
- Published by Springer Nature in Molecular Biotechnology
- Vol. 60 (5) , 362-368
Abstract
Alzheimer’s disease (AD) is the most common neurodegenerative disease, where β-amyloid (Aβ) plays a key role in forming conglomerated senile plaques. The receptor of advanced glycation end products (RAGE) is considered a therapeutic target since it transports Aβ into the central nervous system, favoring the pathology progression. Due to the lack of effective therapies for AD, several therapeutic approaches are under development, being vaccines considered a promising alternative. Herein, the use of the Algevir system was explored to produce in the Schizochytrium sp. microalga the LTB:RAGE vaccine candidate. Algevir relies in an inducible geminiviral vector and led to yields of up to 380 µg LTB:RAGE/g fresh weight biomass at 48-h post-induction. The Schizochytrium-produced LTB:RAGE vaccine retained its antigenic activity and was highly stable up to temperatures of 60 °C. These data demonstrate the potential of Schizochytrium sp. as a platform for high production of thermostable recombinant antigens useful for vaccination against AD.Keywords
Funding Information
- CONACyT (271182, 256063)
This publication has 26 references indexed in Scilit:
- Vaccination against Influenza with Recombinant Hemagglutinin Expressed by Schizochytrium sp. Confers Protective ImmunityPLOS ONE, 2013
- An Aqueous Orally Active Vaccine Targeted Against a RAGE/AB Complex as a Novel Therapeutic for Alzheimer’s DiseaseNeuroMolecular Medicine, 2012
- RAGE is a key cellular target for A -induced perturbation in Alzheimer s diseaseFrontiers in Bioscience-Scholar, 2012
- RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's diseaseFrontiers in Bioscience-Scholar, 2012
- Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer’s diseaseBiotechnology Letters, 2008
- Transgenic potato expressing Aβ reduce Aβ burden in Alzheimer's disease mouse modelFEBS Letters, 2005
- Engineering viral expression vectors for plants: the ‘full virus’ and the ‘deconstructed virus’ strategiesCurrent Opinion in Plant Biology, 2004
- Clinical overview of the synucleinopathiesMovement Disorders, 2003
- The biology of the receptor for advanced glycation end products and its ligandsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2000
- A plant DNA minipreparation: Version IIPlant Molecular Biology Reporter, 1983